Sotera Health Company (NASDAQ:SHC) Receives $20.14 Consensus Target Price from Analysts

Shares of Sotera Health Company (NASDAQ:SHC) have been assigned an average rating of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $20.6667.

SHC has been the topic of several research analyst reports. Citigroup upped their price target on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Wells Fargo & Company cut shares of Sotera Health to an “overweight” rating in a report on Thursday, January 8th. Zacks Research cut shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Royal Bank Of Canada initiated coverage on shares of Sotera Health in a report on Thursday, January 8th. They issued an “outperform” rating and a $24.00 price target on the stock. Finally, Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th.

Sotera Health Trading Down 0.7%

Shares of SHC stock opened at $15.39 on Tuesday. The company’s fifty day simple moving average is $15.04 and its two-hundred day simple moving average is $16.49. The company has a debt-to-equity ratio of 3.66, a current ratio of 2.46 and a quick ratio of 2.24. Sotera Health has a 1 year low of $10.80 and a 1 year high of $19.85. The stock has a market capitalization of $4.39 billion, a price-to-earnings ratio of 57.00 and a beta of 1.82.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a net margin of 6.70% and a return on equity of 42.38%. The business had revenue of $303.44 million for the quarter, compared to analysts’ expectations of $300.68 million. During the same quarter in the previous year, the firm posted $0.21 EPS. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. As a group, analysts anticipate that Sotera Health will post 0.88 earnings per share for the current year.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the company’s stock in a transaction on Friday, March 6th. The shares were sold at an average price of $15.27, for a total value of $152,700,000.00. Following the transaction, the director owned 12,735,301 shares of the company’s stock, valued at approximately $194,468,046.27. This represents a 43.98% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 15.36% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. IFP Advisors Inc increased its holdings in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after purchasing an additional 1,371 shares during the period. Rothschild Investment LLC bought a new position in Sotera Health in the fourth quarter valued at $27,000. True Wealth Design LLC increased its stake in Sotera Health by 389.3% in the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock valued at $32,000 after acquiring an additional 1,456 shares during the last quarter. Root Financial Partners LLC increased its stake in Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after acquiring an additional 1,455 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. bought a new position in Sotera Health in the fourth quarter valued at $40,000. Institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.